We report on the detection of HIV-specific cytotoxic T lymphocytes (CTL) among 23 regular partners of HIV-infected individuals. 15 of the 46 individuals enrolled in the study were positive for HLA-A2.1 typing. Among the 23 contacts studied, 7 were seropositive and 16 were seronegative on repeated tests. None of the 16 seronegative contacts were positive for p24 antigenemia nor were they positive by the lymphocytes coculture assay, although, in two instances HIV-1 DNA could be detected by PCR (in one case using agag SK 38/39 primer, and in the other using a primer for the pol P3/P4 primer). These two individuals remained seronegative for 18 and 36 mo, respectively. HIV-specific cytotoxicity was performed in the 15 HLA-A2.1 subjects (7 indexes, 2 seropositive contacts, and 6 seronegative contacts) and in 4 HLA-matched HIV negative donors. CTL specific for env, gag, or nef proteins could not be detected in unstimulated bulk cultures of peripheral blood lymphocytes in any of the six seronegative contacts. However, using a limiting dilution assay we found an usually high frequency of HIV nef-specific CTL in six seronegative contacts studied. The frequency of CTL precursors (C1TLp) for HIV env and gag was very similar to that observed in seronegative HLAmatched healthy donors. Because no presence of HIV could be demonstrated in these individuals, these findings argue against the possibility of a silent HIV infection and suggest that a CTL response against nef may be involved in a rapid and effective clearance of the virus after sexual exposure. (J. Clin. Invest.
Introduction
The possibility that HIV infection could occur in the absence of demonstrable serum antibodies to HIV has generated concern both in the scientific community and among the general This paper is dedicated to the memory of Fernando Plata. public. By using an ELISA for the detection ofserum p24 antigen, lymphocyte coculture for HIV isolation, and PCR for the identification of HIV DNA in PBL, it is generally possible to detect viremia in patients during the 6 mo preceding seroconversion (1) (2) (3) (4) (5) . In some instances HIV has been detected by PCR or by lymphocyte coculture, respectively, at 12-42 and 11-1 8 mo before seroconversion (3, 5) . However, Imagawa et al. (6) were unable to reisolate HIV in 26 ofthe 27 culture-positive, seronegative men who participated in their initial study. Based on these findings the authors advanced the hypothesis of incomplete rather than latent, persistent infection (6) . In other studies conducted in high risk seronegative individuals, the possibility ofsilent viral infection in the absence ofseroconversion remains very controversial (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . It has been appreciated that a specific cytotoxic T lymphocyte (CTL)' response to HIV is of much greater magnitude than that observed in almost any other viral infection. This is thought to be one of the main factors contributing to the long symptom-free periods observed in AIDS patients ( 19 (20) . It is conceivable that a rapid recruitment and expansion of these cells after HIV exposure could play an important role in protection against HIV infection. In recent studies, cell-mediated immune responses to HIV have been detected in seronegative homosexual men exposed to HIV (21 ). Moreover, strong HIV-specific CTL activity was observed in uninfected infants born from HIV-infected mothers (22, 23) .
In this study we sought the presence of CTL specific for three HIV proteins among seronegative partners of HIV-infected individuals. We found high frequency of CTL precursor (CTLp) ..gainst the nef antigen in six seronegative contacts. These data are interpreted as evidence that CTL could have played a protective role in killing HIV-infected cells immediately after infection via sexual exposure and that they preexisted in the immune system as memory CTL.
Methods
Subjects. 23 HIV-infected patients and their 23 regular heterosexual partners were enrolled in this study. One member of each couple, whether male or female, was known to be HIV seropositive (index).
The heterosexual partner (contact) excluded any other possible exposure to HIV. The couples enrolled in this study maintained a stable, unprotected sexual relationship (condoms were never used) for at least 2 yr at the onset of the study.
15 index cases were male and 8 were female. Nine of these patients presented with symptomatic HIV infection and were classified in group IV according to the Centers for Disease Control (CDC) classification. Two had AIDS. The mean CD4 cell count was 319 x 106/liter (range, 5-1,080), while 16 of the index cases had a CD4 cell count < 400 X 106/liter ( Table I ). All of the 23 contact cases were asymptomatic, except for the presence of persistent generalized lymphadenopathy in three of the seven seropositive contacts. 2 yr after the end of the study the HIV -contacts remain negative and in good condition while most of the HIV + individuals have died.
Virologic studies. Detection ofserum HIV antibody was performed using both ELISA and Western blot analysis. Serum p24 antigen detection was performed by immunoassay (Abbott Laboratories, North Chicago, IL).
A standard cocultivation procedure was used for HIV isolation. PBMC were isolated from heparinized blood of each individual by Ficoll-Hypaque density gradient centrifugation. 3 X 106 cells were used for cocultivation with 9 X 106 PHA-stimulated normal PBMC from healthy donors. The culture supernatants were tested directly for HIV-1 p24 antigen twice a week for a period of 6 wk (24).
The PCR assay detected any HIV-l DNA present in uncultured PBMC. Two primer pairs were used: SK38/39 for a gag sequence (25) and P3/P4 for a pol sequence (26) , along with their corresponding oligonucleotide probes. 1 (27) .
HIV-specific cytotoxicity. Murine cell clones stably expressing HIV-I (BRU) gene products were produced by transfection of cloned env, gag, and nefgenes into P815 mastocytoma cells. Double transfectants expressing HIV-I gene products and human HLA-A2. 1 were produced as described previously (28) (29) (30) (Table II) . These two subjects were tested for the presence of antibodies to HIV 18 and 26 mo later, respectively, and remained seronegative.
HI V-specificcytotoxicity. The analysis ofHIV-specific cytotoxicity from PBL was performed in 19 HLA-A2 subjects, using the P81 5-A2, P81 5-A2-env, P81 5-A2-gag, and P81 5-A2-nef transfectants as target cells.
Among the seropositive subjects, HIV-specific cytotoxicity against env or gag was detected in three indexes using unstimulated CTL from PBMC (data not shown). By limiting dilution the relative frequencies of HIV-specific CTLp against env, gag, or nefproteins were either undetectable or lower than in HLAmatched HIV-negative donors (Table III) . The HIV-specific CTLp frequencies were > 5 X I04 in five ofnine cases. Interestingly, all five patients had a CD4 cell count > 400 X 106/liter, while the eight patients with undetectable HIV-specific CTLp had a CD4 cell count < 400 X 106/liter. The two patients with the highest CTLp frequencies for env, gag, and n efantigens had the highest CD4 cell counts. These two patients are still alive after 42 and 37 mo, with a CD4 cell count of 354 and 294 X 106/liter.
Among the seronegative individuals, HIV-specific cytotoxicity could not be detected in bulk cultures against env, gag, or nef proteins in any of the five HLA-A2 seronegative contacts nor in the four HLA-A2 healthy donors. In contrast, by LDA we found high frequencies of HIV env-specific CTLp in all 10 individuals (Table III) HIV gag-specific CTLp were detected with relative frequencies > 5 X 10 -4 in two ofsix contacts as well as two offour donors. HIV nef-specific CTLp could be detected in all six contacts, with relative frequencies varying from 6 to 25 x 10-4, values higher than in the four healthy donors (0-3 X l0-4) (P < 0.02; Mann-Whitney U test).
Discussion
In this paper we describe six seronegative individuals in stable unprotected sexual relationships with an HIV-infected partner that remained protected from viral infection and demonstrated to have high frequency of CTLp for HIV n efprotein. Failure to develop HIV infection 2 yr or longer after beginning a relationship with an HIV-infected individual while having a high number ofCTLp for HIV n efprotein is unprecedented and deserves discussion concerning: (a) the origin of the CTL response against n efin these individuals, and (b) a cause-effect relationship between high frequency of CTLp and protection from HIV infection. In conclusion, we demonstrated a high frequency of CTLp against nef in seronegative individuals exposed to HIV infection by sexual contact. These finding have general implications for understanding the mechanisms of immune response to HIV infection, for new approaches to diagnosis and prognosis of infected individuals, and for designing strategies of vaccination and prophilaxis against HIV.
